NL-OMON39367已完成不适用
the Dutch Stent Thrombosis Study - DUST
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •all patients suffering a stent thrombosis
排除标准
- •Abcense of an informed consent.;If a case or matched control patient dies before written Informed Consent could be obtained the clinical data will be used for the study, but only if the researcher doesn*t have any suggestion that the patient would have declined his consent if he still would have been alive. The researcher will write a note in the CRF stating this assumption. The family will not be contacted and no blood samples will be stored.
研究者
相似试验
招募中
不适用
The National Dutch Stent Thrombosis Registryin-stent thrombosisblood clot in previously implanted coronary stent10011082NL-OMON47084Sint Antonius Ziekenhuis1,000
Unknown
不适用
Biomarkers for thrombosislower extremity deep-vein thrombosisNL-OMON25104Academic Medical Center1,000
招募中
不适用
Trombocytopathy in the NetherlandsPlatelet function disorders TrombocytopathieNL-OMON22771MC Utrecht150
未知
2 期
DU-176b Phase IIb clinical study (venous thromboembolism): Japan-Taiwan multicenter randomized double-blind dose-finding study using Enoxaparin as a reference in patients undergoing total hip replacementPatients undergoing total hip arthroplastyJPRN-jRCT2080220798DAIICHISANKYO Co.,Ltd.210
未知
3 期
DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220743DAIICHISANKYO Co.,Ltd.600